Dec 14, 2021 The CJEU’s Decision in Boehringer Ingelheim v Tax and Customs Appeals Directorate, Hungary By Maura Dineen Tudor Nedelea Patrick O'Donovan On 6 October 2021 the Court of Justice of the European Union (the “CJEU”) released its judgment in the case of Boehringer Ingelheim RCV...
Dec 14, 2021 Drug price controls make industry critics feel better, but won’t make people feel healthier By Kirsten Axelsen Please note: Article was first published in The American Enterprise Institute for Public Policy Research In Build Back Better, price...
Dec 13, 2021 Do medical devices have systematic bias? By Kate Black Anna Ward An investigation has been launched by the UK’s Department of Health and Social Care (“DHSC”) with the overall aim of improving healthcare...
Dec 06, 2021 The importance of regional innovation hubs in supporting the UK's Life Sciences Vision By Lyndsey Hudson Following on from my recent comments about the UK being a viable location to be a life sciences startup - with the right governmental...
Dec 03, 2021 Portugal establishes new rules on the revision of the prices for medicinal products By Mariana Ricardo Ordinance no. 280/2021, dated 3 December (entering into force on December 4, 2021) creates an exceptional criterion to be used in the...